Advanced search
Publication Cover
Acta Oncologica Volume 59, 2020 - Issue 12
Journal homepage
1,109
Views
2
CrossRef citations to date
0
Altmetric
LETTERS TO THE EDITOR: CANCER DIAGNOSTICS AND PROGNOSTICS

An easily adaptable validated risk score predicts cancer-specific survival in stage II colon cancer

Eetu Heerväa Department of Oncology, University of Turku and Turku University Hospital, Turku, FinlandCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6134-1170View further author information
ORCID Icon,
Vesa Väliahoa Department of Oncology, University of Turku and Turku University Hospital, Turku, FinlandView further author information
,
Tapio Salminenb Department of Oncology, Tampere University Hospital and University of Tampere, Tampere, FinlandView further author information
,
Lasse Nieminenc Department of Pathology, Fimlab Laboratories, Tampere University, Tampere, Finland;d Department of Medicine and Health Technology, Tampere University, Tampere, FinlandView further author information
,
Anu Carpelane Department of Digestive Surgery, University of Turku and Turku University Hospital, Turku, FinlandView further author information
,
Samu Kurkif Auria Biobank, University of Turku and Turku University Hospital, Turku, FinlandView further author information
,
Jari Sundströmg Department of Pathology, University of Turku and Turku University Hospital, Turku, FinlandView further author information
,
Heikki Huhtinene Department of Digestive Surgery, University of Turku and Turku University Hospital, Turku, FinlandView further author information
,
Arto Rantalae Department of Digestive Surgery, University of Turku and Turku University Hospital, Turku, FinlandView further author information
,
Olli Carpéng Department of Pathology, University of Turku and Turku University Hospital, Turku, Finland;h Department of Pathology and Research Program in Systems Oncology, University of Helsinki and Diagnostic Center, Helsinki University Hospital, Helsinki, FinlandView further author information
,
Heikki Minna Department of Oncology, University of Turku and Turku University Hospital, Turku, FinlandORCID Iconhttps://orcid.org/0000-0002-5878-4333View further author information
ORCID Icon,
Pia Österlundb Department of Oncology, Tampere University Hospital and University of Tampere, Tampere, FinlandORCID Iconhttps://orcid.org/0000-0002-7124-3515View further author information
ORCID Icon,
Annika Ålgarsa Department of Oncology, University of Turku and Turku University Hospital, Turku, Finland;i Medicity Research Laboratory, University of Turku, Turku, FinlandView further author information
&
Raija Ristamäkia Department of Oncology, University of Turku and Turku University Hospital, Turku, FinlandView further author information
 show all
Pages 1503-1507 | Received 14 May 2020, Accepted 25 Sep 2020, Published online: 12 Oct 2020

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.